HEPARAN-SULFATE PROTEOGLYCANS ARE INVOLVED IN THE LIPOPROTEIN LIPASE-MEDIATED ENHANCEMENT OF THE CELLULAR-BINDING OF VERY LOW-DENSITY AND LOW-DENSITY LIPOPROTEINS

被引:108
作者
MULDER, M
LOMBARDI, P
JANSEN, H
VANBERKEL, TJC
FRANTS, RR
HAVEKES, LM
机构
[1] TNO,IVVO,GAUBIUS LAB,POB 430,2300 AK LEIDEN,NETHERLANDS
[2] DEPT BIOCHEM & INTERNAL MED,ROTTERDAM,NETHERLANDS
[3] CTR BIOPHARMACEUT SCI,LEIDEN,NETHERLANDS
[4] MGC,DEPT HUMAN GENET,LEIDEN,NETHERLANDS
关键词
D O I
10.1016/0006-291X(92)91664-C
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We found that LPL enhances the binding to HepG2 cells and fibroblasts of both VLDL and apoE free LDL. In the presence of 1.7 μg/ml of purified bovine LPL, the binding of LDL and VLDL was up to 60 fold increased as compared to the control binding. In addition, LPL enhances the binding in LDL-receptor negative fibroblasts to the same extent as it does in normal fibroblasts. The presence of 10 mM of EGTA could not prevent the LPL-mediated enhancement of the binding of both LDL and VLDL to fibroblasts, indicating that the binding is calcium independent. Furthermore, up- and down regulation of the LDL receptor did not influence the binding of these lipoproteins in the presence of LPL. Strikingly, we found that the enhancing effect of LPL on the binding of LDL and VLDL to HepG2 cells could be abolished by preincubation of the cells with heparinase, suggesting that heparan sulphate proteoglycans are involved in the LPL-mediated stimulation. We hypothesize that the enhancement of the cellular binding of LDL and VLDL in the presence of LPL is caused by an LPL-bridging between proteoglycans present on the plasma membrane and the lipoproteins, and that the LDL receptor and LRP are not involved. © 1992.
引用
收藏
页码:582 / 587
页数:6
相关论文
共 22 条
  • [1] THE LDL RECEPTOR RELATED PROTEIN, LRP, IS AN APOLIPOPROTEIN-E-BINDING PROTEIN
    BEISIEGEL, U
    WEBER, W
    IHRKE, G
    HERZ, J
    STANLEY, KK
    [J]. NATURE, 1989, 341 (6238) : 162 - 164
  • [2] LIPOPROTEIN-LIPASE ENHANCES THE BINDING OF CHYLOMICRONS TO LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN
    BEISIEGEL, U
    WEBER, W
    BENGTSSONOLIVECRONA, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) : 8342 - 8346
  • [3] METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS
    BILHEIMER, DW
    LEVY, RI
    EISENBERG, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) : 212 - +
  • [4] LIPOPROTEIN RECEPTORS IN THE LIVER - CONTROL SIGNALS FOR PLASMA-CHOLESTEROL TRAFFIC
    BROWN, MS
    GOLDSTEIN, JL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (03) : 743 - 747
  • [5] BROWN MS, 1991, CURR OPIN LIPIDOL, V2, P65
  • [6] CISAR LA, 1989, J BIOL CHEM, V264, P1767
  • [7] ENHANCED METABOLISM OF NORMOLIPIDEMIC HUMAN-PLASMA VERY LOW-DENSITY LIPOPROTEIN IN CULTURED-CELLS BY EXOGENOUS APOLIPOPROTEIN-E-3
    EISENBERG, S
    FRIEDMAN, G
    VOGEL, T
    [J]. ARTERIOSCLEROSIS, 1988, 8 (05): : 480 - 487
  • [8] HAMILTON RL, 1990, J LIPID RES, V31, P1589
  • [9] INTERACTION OF BETA-VERY-LOW-DENSITY LIPOPROTEINS WITH RAT-LIVER CELLS
    HARKES, L
    VANDUIJNE, A
    VANBERKEL, TJC
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1989, 180 (01): : 241 - 248
  • [10] STIMULATION OF THE LDL RECEPTOR ACTIVITY IN THE HUMAN HEPATOMA-CELL LINE HEP G2 BY HIGH-DENSITY SERUM FRACTIONS
    HAVEKES, LM
    SCHOUTEN, D
    DEWIT, ECM
    COHEN, LH
    GRIFFIOEN, M
    VANHINSBERGH, VWM
    PRINCEN, HMG
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 875 (02) : 236 - 246